Clinical trial
ChiCGB Versus BEAM With Autologous Stem-Cell Transplantation in High-risk Hodgkin and Non-Hodgkin Lymphoma - A Prospective, Multi-centered, Randomized Clinical Trial
NCT05466318 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ChiCGB Versus BEAM With Autologous Stem-Cell Transplantation in High-risk Hodgkin and Non-Hodgkin Lymphoma - A Prospective, Multi-centered, Randomized Clinical Trial
- Lead sponsor
- Sichuan University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- December 30, 2025
- Enrollment
- 306 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.